DoE-derived continuous and robust process for manufacturing of pharmaceutical-grade wide-range LNPs for RNA-vaccine/drug delivery.

MLA

Nag, Kakon, et al. “DoE-Derived Continuous and Robust Process for Manufacturing of Pharmaceutical-Grade Wide-Range LNPs for RNA-Vaccine/Drug Delivery.” Scientific Reports, vol. 12, no. 1, June 2022, pp. 1–11. EBSCOhost, https://doi.org/10.1038/s41598-022-12100-z.

APA

Nag, K., Sarker, M. E. H., Kumar, S., Khan, H., Chakraborty, S., Islam, M. J., Baray, J. C., Khan, M. R., Mahmud, A., Barman, U., Bhuiya, E. H., Mohiuddin, M., & Sultana, N. (2022). DoE-derived continuous and robust process for manufacturing of pharmaceutical-grade wide-range LNPs for RNA-vaccine/drug delivery. Scientific Reports, 12(1), 1–11. https://doi.org/10.1038/s41598-022-12100-z

Chicago

Nag, Kakon, Md. Enamul Haq Sarker, Samir Kumar, Habiba Khan, Sourav Chakraborty, Md. Jikrul Islam, Juwel Chandra Baray, et al. 2022. “DoE-Derived Continuous and Robust Process for Manufacturing of Pharmaceutical-Grade Wide-Range LNPs for RNA-Vaccine/Drug Delivery.” Scientific Reports 12 (1): 1–11. doi:10.1038/s41598-022-12100-z.